A weekly digest covering regulatory updates, industry developments, safety alerts, market research, and Canadian local news across the sexual wellness and sex tech sectors. Compiled by the Dr.Chen Wellness Editorial Team.

This week's brief spans a notable FDA safety recall, an expanding at-home sexual health diagnostic, an upcoming European trade event, a new intimate tech product category launch, fresh global market data on condoms, and a Canadian public health success story rooted in rapid diagnostic testing. Taken together, these stories reflect a sector where consumer safety, clinical innovation, and brick-and-mortar industry activity are all advancing simultaneously — with regulatory action and diagnostic access continuing to reshape what "sexual wellness" means in 2026.


1. Primal Herbs "Volume" Recalled for Undeclared Sildenafil [SAFETY — REGULATORY]

Fact: Primal Supplements Group LLC issued a voluntary nationwide recall of all orders of Primal Herbs Volume placed between July 2 and September 19, 2025, after FDA laboratory analysis confirmed the product contains sildenafil not listed on its label. The recall was announced on approximately February 27, 2026, and covered on ConsumerLab.com as of March 12, 2026. The product — a green-labelled, 8.5 oz herbal supplement sold online at primalherbs.com — was distributed across the United States.

Background: Sildenafil is the active ingredient in the FDA-approved prescription drug Viagra, used to treat erectile dysfunction. The FDA has been tracking a recurring pattern of undeclared prescription drugs in herbal supplements marketed as "natural" sexual performance products.

Significance: This is the latest in a series of FDA recall actions targeting herbal sexual supplements containing hidden pharmaceutical ingredients. Canadian consumers and retailers should be aware that such products are commonly sold via cross-border e-commerce platforms. This can reasonably be viewed as an ongoing industry-wide compliance gap, where "natural" labelling does not guarantee the absence of potent prescription-strength ingredients. Consumers with cardiovascular conditions or those taking nitrate medications face the highest risk.


2. Visby Medical's At-Home STI PCR Test Expands Nationwide via Quest and Labcorp [REGULATORY / TECH]

Fact: In January 2026, Visby Medical announced partnerships with Quest Diagnostics and Labcorp to expand consumer access to its Women's Sexual Health Test — the first FDA-authorized over-the-counter PCR test for sexually transmitted infections. The test, which screens for chlamydia, gonorrhea, and trichomoniasis, received FDA De Novo authorization on March 28, 2025, and has been available through questhealth.com since November 2025. The January 2026 announcement adds Labcorp's distribution network, significantly broadening national reach.

Background: At-home PCR-based STI testing represents a significant shift from traditional clinic-based screening. The Visby test delivers results in approximately 30 minutes via a secure app, without a prescription, and was validated with 97–100% accuracy rates across all three pathogens tested.

Significance: Democratized, accurate STI testing has long been a public health priority. This expansion may suggest a shift in how sexual health screening reaches underserved or stigma-affected populations — including rural communities and those with limited healthcare access. (Editorial note: While the product is U.S.-authorized, the model could inform future regulatory discussions in Canada around OTC molecular diagnostic access.)


3. EroFest 2026 Returns to Prague April 10–11 with New Alterno Zone [INDUSTRY — EUROPE]

Fact: EroFest 2026, one of Europe's largest erotic trade fairs, is scheduled for April 10–11, 2026, at PVA EXPO Prague – Letňany in the Czech Republic. The 11th edition of the event expects more than 20,000 visitors and over 150 exhibitors from across Europe. SVAKOM, the global intimate tech brand, returns as General Sponsor for the third consecutive year. A new thematic zone — Alterno Chambers — focused on alternative sexuality and community culture, debuts this year in collaboration with Hell Events, according to EAN Online.

Background: EroFest is the primary erotic consumer and trade fair in Central Europe, attracting brands, distributors, retailers, and consumers. It sits alongside other European industry events and the annual Erotico fair circuit as a barometer of European intimate product trends.

Significance: SVAKOM's continued headline sponsorship signals its commitment to European distribution and brand-building. The introduction of an alternative sexuality zone can reasonably be viewed as a response to growing mainstream interest in kink-adjacent categories. For Canadian distributors monitoring European product launches, EroFest serves as an early preview of products likely entering North American markets within 6–12 months.


4. OTOUCH Launches YU-BattleHelm: An All-in-One Intimate Tech Kit [SEX TECH / PRODUCT]

Fact: OTOUCH, a global intimate technology brand, has introduced the YU-BattleHelm, described by European trade outlet EAN Online as a "refined all-in-one intimate tech experience." The product is a two-component kit consisting of a silky fingertip vibrator and a vibrating extender designed to be used in combination. Per the EAN Online announcement, the product is positioned for retail distribution through European wholesale channels as part of OTOUCH's 2026 product lineup.

Background: OTOUCH has positioned itself in the premium intimate tech segment, frequently exhibiting at international trade events and targeting both solo and partnered use cases. The "kit" format — bundling complementary stimulation devices — reflects a growing design trend toward multi-function intimate products in a single retail unit.

Significance: Bundled intimate tech products offer retailers improved margin-per-unit and consumers clearer value propositions. (Editorial note: The category of "coordinated stimulation kits" is emerging across several brands simultaneously, suggesting a broader shift in how intimate tech is merchandised and experienced rather than as single-function devices.)


5. Global Condom Market Projected to Reach $22.57 Billion by 2030 [MARKET RESEARCH]

Fact: A market report published February 23, 2026 via GlobeNewswire projects the global condom market to expand from $13.36 billion in 2025 to $14.87 billion in 2026, growing at an 11.3% CAGR and reaching $22.57 billion by 2030. Key companies cited include Reckitt Benckiser, Church & Dwight, Humanwell Healthcare, Okamoto Industries, Mankind Pharma, and Karex Berhad. Growth is attributed to rising sexual health awareness, wider institutional distribution programs, advancements in latex processing, and expanding e-commerce access.

Background: Condoms remain the only contraceptive method that also provides protection against sexually transmitted infections, making the category central to both contraceptive and STI-prevention health strategies globally. Market growth in this segment often reflects public health programming investment as well as commercial demand.

Significance: An 11.3% CAGR is notably high for a mature product category. This can reasonably be viewed as reflecting both renewed public health emphasis on barrier-method STI prevention and ongoing expansion of e-commerce channels in regions previously underserved by pharmacy distribution. For Canadian retailers, the data points to condoms as a higher-growth category than many assume.


6. Alberta Syphilis Rates Decline After Rapid Point-of-Care Testing Rollout [OFFICIAL — CANADA]

Fact: A peer-reviewed study published in Clinical Infectious Diseases (Oxford Academic), led by University of Alberta researcher Dr. Ameeta Singh in collaboration with Unity Health Toronto's St. Michael's Hospital, found that the rollout of syphilis rapid/point-of-care tests (RPOCTs) was associated with a 15% decline in syphilis positivity in Edmonton after its 2020 introduction, and a 25% provincial decline after the province-wide scale-up in March 2022. Reported by the University of Alberta's Folio publication and covered in The Gateway in February 2026, the study used interrupted time series analysis of Alberta Health data. Health Canada approved the rapid test in 2023 after the team found it 98% accurate.

Background: Alberta declared a syphilis outbreak in July 2019. By 2022, the province was reporting over 3,300 infectious syphilis cases annually — a rate more than 17 times higher than 2014 levels. The rapid test allows same-day results and immediate treatment with a single injectable dose of penicillin.

Significance: This study provides real-world Canadian evidence that accessible, rapid STI diagnostics can produce measurable population-level impact within two to three years of implementation. The research may reasonably inform future national sexual health policy, particularly in provinces where syphilis rates remain elevated. Recovery Alberta's parallel data showing declining rates in jails and remand centres adds further weight to the findings.


7. OEJ Novelty Unveils Three New Pleasure Devices for 2026 Retail Rollout [INDUSTRY / PRODUCT]

Fact: On March 30, 2026, OEJ Novelty announced three upcoming retail-ready pleasure devices via JRL CHARTS trade media: the Suxs, the Spot On Deluxe, and the Rough Rabbit. The Suxs features a linear motor suction system with adjustable intensity and a precision tip; the Spot On Deluxe offers a 64-mode vibration range with an LCD battery display and Type-C charging; and the Rough Rabbit is an addition to the brand's rabbit vibrator lineup. All three products are built with body-safe silicone.

Background: OEJ Novelty also launched a next-generation e-commerce superstore in March 2026 and showcased its 2026 product lineup at the AVN AEE Expo in Las Vegas in February. The company appears to be executing an active brand-building and retail distribution push throughout the first half of 2026.

Significance: The simultaneous announcement of three SKUs alongside a new consumer-facing storefront suggests OEJ Novelty is targeting expanded retail shelf placement for H2 2026. The inclusion of an LCD battery display on the Spot On Deluxe reflects consumer demand for product transparency at the device level — a trend increasingly common in mid-tier vibrators entering mainstream retail.


Editors' Note: What This Week's Stories Mean Together

Three threads run through this week's coverage. The first is the persistent challenge of supplement safety: the Primal Herbs recall is the latest in a years-long pattern of herbal sexual supplements concealing prescription-level ingredients. Despite ongoing FDA enforcement, the category continues to generate new recalls, pointing to a structural gap between supplement marketing freedoms and consumer protection. This is an issue with direct cross-border relevance for Canada, where similar products circulate through e-commerce channels.

The second thread is the maturation of at-home sexual health diagnostics. Visby Medical's expansion through major laboratory networks represents a meaningful shift: PCR-level STI testing accuracy, now available without a clinical visit or prescription. When paired with the Alberta syphilis story — which demonstrates that rapid point-of-care testing deployed at scale can measurably reduce STI transmission — this week's coverage collectively makes a case for rethinking where sexual health screening happens and who it reaches. The clinical and consumer-facing sides of this shift are converging.

The third thread is industry preparation for the back half of 2026. OEJ Novelty's product announcements, OTOUCH's new kit format, and the imminent EroFest in Prague all signal active trade positioning heading into the summer trade show cycle and year-end retail season. Product innovation continues to trend toward bundled utility, multi-function design, and measurable user-facing features — reflecting an industry that is increasingly competing not just on sensation but on design credibility and product transparency. — Dr.Chen Wellness Editorial Team, April 2026


References

  1. U.S. Food and Drug Administration. (2026, February/March). Primal Herbs Issues Voluntary Nationwide Recall of Primal Herbs Volume Due to Undeclared Sildenafil. FDA Safety Alerts. https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/primal-herbs-issues-voluntary-nationwide-recall-primal-herbs-volume-due-undeclared-sildenafil
  2. ConsumerLab.com. (2026, March 12). Primal Herbs Volume Recalled. ConsumerLab Recall Alerts. https://www.consumerlab.com/recalls/14966/primal-herbs-volume-recalled/
  3. Visby Medical Inc. (2026, January 8). Visby Engages Quest and Labcorp to Broaden Consumer Access to First At-Home, FDA-Authorized PCR Test for STIs. PharmiWeb. https://www.pharmiweb.com/press-release/2026-01-08/visby-engages-quest-and-labcorp-to-broaden-consumer-access-to-first-at-home-fda-authorized-pcr-test
  4. EAN Online. (2026, March/April). Erofest 2026 will bring world stars, dozens of shows and a new Alterno zone. EAN Online. https://www.ean-online.com/events/erofest-2026-will-bring-world-stars-dozens-of-shows-and-a-new-alterno-zone/
  5. EAN Online. (2026). OTOUCH Introduces YU-BattleHelm, a Refined All-in-One Intimate Tech Experience. EAN Online Product News. https://www.ean-online.com/product-news/otouch-introduces-yu-battlehelm-a-refined-all-in-one-intimate-tech-experience/
  6. GlobeNewswire / Research and Markets. (2026, February 23). Condom Market Report 2026-2035: A $22.57 Billion Industry by 2030. GlobeNewswire. https://www.globenewswire.com/news-release/2026/02/23/3242390/28124/en/Condom-Market-Report-2026-2035-A-22-57-Billion-Industry-by-2030-with-Reckitt-Benckiser-Church-Dwight-Humanwell-Healthcare-Okamoto-Industries-Mankind-Pharma-Karex-Berhad-Leading.html
  7. University of Alberta Folio. (2025, December). New cases of syphilis in Alberta drop after introduction of rapid testing with immediate treatment. University of Alberta Folio. https://www.ualberta.ca/en/folio/2025/12/new-cases-syphilis-in-alberta-drop-after-introduction-of-rapid-testing-immediate-treatment.html
  8. JRL CHARTS. (2026, March 30). OEJ Novelty Unveils 3 New Pleasure Products Set to Hit Retail Shelves. JRL CHARTS. https://jrlcharts.com/2026/03/30/oej-novelty-unveils-3-new-pleasure-products-set-to-hit-retail-shelves/
四月 03, 2026 — Dr. Chen

Leave a comment

Please note: comments must be approved before they are published.